Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5143240 | Current Opinion in Chemical Biology | 2017 | 6 Pages |
Abstract
The rational/structure-based design and/or combinatorial development of molecules capable of selectively binding to a protein, represents a promising strategy for a range of biomedical applications, in particular the inhibition of disease-associated protein-ligand interactions. The design of such protein binding molecules is often based on an antibody against the target protein, or involves the generation of smaller molecules that retain the binding characteristics of the antibody. Alternatively, protein binding molecules can be selected from protein libraries based on small, stably folded protein scaffolds presenting flexible loops, which are randomized in the libraries. In addition to recombinantly synthesized molecules, synthetic antibody paratope mimetic peptides have emerged as promising molecules for the design of antibody mimics.
Related Topics
Physical Sciences and Engineering
Chemistry
Chemistry (General)
Authors
Christina HauÃner, Johannes Lach, Jutta Eichler,